UNSPSC 85641752: Revision of synthetic substitute in upper extremity subcutaneous tissue and fascia, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of synthetic substitute in upper extremity subcutaneous tissue and fascia, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JWV0JZ

UNSPSC 85641752 Revision of synthetic substitute in upper extremity subcutaneous tissue and fascia, open approach is a Commodity code that shows little relevant recent activity. The code nominally describes a surgical procedure on upper-extremity soft tissue, but the recent state and local opportunities tagged under it address occupational medical surveillance, disability medical evaluations, pharmacy benefit management, surgical center-of-excellence networks, emergency medical services for detained youth, and temporary clinical staffing—none of which aligns with orthopedic implant or synthetic tissue revision. The mismatch suggests that either the tagging is incidental or the code is being used as a catch-all for healthcare services procurement more broadly.

Across the opportunities present, the issuing bodies are a mix of state departments (Washington State Department of Transportation on behalf of Washington State Ferries), counties (Harris County, Collier County, Santa Clara County), and cities (Phoenix, Long Beach), with recent activity concentrated in Arizona, Florida, California, and Washington. Representative opportunities include the City of Phoenix Retirement Office's RFP (RTMRFP26001, due October 16, 2026) for independent medical evaluation services supporting disability pension determinations; the Washington State Department of Transportation's RFP (RFP20260825, due October 9, 2026) for occupational medical surveillance across 14 ferry system locations; and Collier County's RFP (258414, due April 9, 2026) for pharmacy benefit management services managing approximately $8.7 million in annual pharmacy spending. Given the absence of surgical procedure or implant-related solicitations under this code, pursuit activity should focus on whether the issuing body's use of the code reflects actual need within the code's nominal scope or misclassification of healthcare administration work.